Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2 by Hooijberg J H, Broxterman H J, Kool M, Assaraf Y G, Peters G J, Noordhuis P, Scheper R J, Borst P, Pinedo H M, Jansen G in Cancer research (1999).

[PMID: 10363967] PubMed


Transfection of multidrug resistance proteins (MRPs) MRP1 and MRP2 in human ovarian carcinoma 2008 cells conferred a marked level of resistance to short-term (1-4 h) exposure to the polyglutamatable antifolates methotrexate (MTX; 21-74-fold), ZD1694 (4-138-fold), and GW1843 (101-156-fold). Evidence for MRP-mediated antifolate efflux relies upon the following findings: (a) a 2-3.3-fold lower accumulation of [3H]MTX and subsequent reduced formation of long-chain polyglutamate forms of MTX; (b) reversal of MTX resistance by probenecid in both transfectants, and (c) ATP-dependent uptake of [3H]MTX in inside-out vesicles of MRP1 and MRP2 transfectants. This report provides a mechanistic basis for resistance to polyglutamatable antifolates through an MRP-mediated drug extrusion.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.